出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2021年12月
末梢血管用デバイス市場: タイプ（血管形成術用バルーン＆ステント、カテーテル、血管内動脈瘤修復用ステントグラフト、血小板修復デバイス、ガイドワイヤー、血管閉鎖デバイス、バルーン拡張用デバイス）- 2026年までの世界予測
Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Guidewires, Vascular Closure Devices, Balloon Inflation Devices) – Global Forecast to 2026
| ページ数 | 330 |
| 図表数 | 542 |
| 種別 | 英文調査報告書 |
| 価格 |
The global peripheral vascular devices market size is projected to reach USD 13.4billion by 2026 from USD 10.3billion in 2021, at a CAGR of 5.3% from 2021 to 2026. The growth of this market is driven by rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases, favorable reimbursement scenario for peripheral vascular procedures, Increased number of product approvals, increased prevalence of diabetes, and rising rate of tobacco consumption.
“Hemodynamic flow alteration devices in the product segment to witness the highest growth during the forecast period.”
Based on the product, the peripheral vascular devices market is segmented into angioplasty balloon, angioplasty stent, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, other peripheral vascular devices. The Embolic Protection Devices segment is projected to grow at the highest CAGR during the forecast period. The major factors contributing to the growth of this market are increasing investments in new technology development and the growing number of regulatory approvals for these devices, and venture capital funding for the development of advanced EPDs.
“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the peripheral vascular devices market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacificisprojected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising geriatric population, increasing awareness among surgeons about the benefits of minimally invasive surgeries, and the rising patient population base for target diseases in several APAC countries.
Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (32%), Tier 2(44%), and Tier 3 (24%)
• By Designation: C-level (30%), Director-level (34%), and Others (36%)
• By Region: North America (40%), Europe (28%), AsiaPacific(20%), and Rest of the World(12%)
List of Companies Profiled in the Report
•Medtronic (Ireland)
•Boston Scientific Corporation (US)
•Abbott (US)
•Becton, Dickinson and Company (US)
•Terumo Corporation (Japan)
•Cardinal Health (US)
•B. Braun Melsungen AG (US)
•Merit Medical Systems (US)
•Penumbra, Inc.(US)
•Koninklijke Philips N.V.( Netherlands)
•iVascular S.L.U (Spain)
•Biosensors International Group Ltd. (Singapore)
•BIOTRONIK (Germany)
•AMG International GmbH (US)
•ENDOCOR GmbH (Germany)
•Meril Life Sciences Pvt. Ltd. (India)
•Alvimedica (Turkey)
•Cardionovum GMBH (Germany)
•SMT (India)
•Medinol Ltd. (Israel)
•Andramed GMBH (Germany)
•Cook (US)
•Rex Medical (US)
•Degania Silicone Ltd. (Israel)
•BrosMed Medical (China)
Research Coverage:
This report studies the peripheral vascular devicesmarket based on product,and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarketswith respect to their growth trends, prospects, and contributions to the total peripheral vascular devices market. The report forecasts the revenue of the market segments with respect to five major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
•Market Penetration: Comprehensive information on peripheral vascular devices productsoffered by the top 25players in the peripheral vascular devices market. The reportanalyzes theperipheral vascular devices market by product,and region.
•Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devicesacross key geographic regions.
•Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the peripheral vascular devices market
•Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the peripheral vascular devices market
目次
1INTRODUCTION49
1.1OBJECTIVES OF THE STUDY49
1.2MARKET DEFINITION49
1.3MARKET SCOPE50
1.3.1MARKET SEGMENTATION50
1.3.2YEARS CONSIDERED FOR THE STUDY51
1.4CURRENCY51
1.5LIMITATIONS51
1.6STAKEHOLDERS52
1.7SUMMARY OF CHANGES52
2RESEARCH METHODOLOGY53
2.1RESEARCH DATA53
FIGURE 1RESEARCH DESIGNS53
2.1.1SECONDARY DATA54
2.1.1.1Key data from secondary sources54
2.1.2PRIMARY DATA55
FIGURE 2PRIMARY SOURCES55
2.1.2.1Key data from primary sources56
2.1.2.2Key industry insights57
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION57
2.2MARKET SIZE ESTIMATION58
FIGURE 4MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH58
2.2.1GROWTH FORECAST59
FIGURE 5CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS59
FIGURE 6TOP-DOWN APPROACH60
2.3MARKET BREAKDOWN AND DATA TRIANGULATION61
FIGURE 7DATA TRIANGULATION METHODOLOGY61
2.4ASSUMPTIONS FOR THE STUDY62
2.5RISK ASSESSMENT62
TABLE 1RISKS62
2.6COVID-19 HEALTH ASSESSMENT63
2.7COVID-19 ECONOMIC ASSESSMENT63
2.8ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO63
FIGURE 9RECOVERY SCENARIO OF THE GLOBAL ECONOMY65
3EXECUTIVE SUMMARY66
FIGURE 10ANGIOPLASTY STENTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)66
FIGURE 11ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET,
BY TYPE, 2021 VS. 2026 (USD MILLION)67
FIGURE 12INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION)67
FIGURE 13CATHETERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)68
FIGURE 14ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)68
FIGURE 15PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION)69
FIGURE 16HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION)69
FIGURE 17OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION)70
FIGURE 18GEOGRAPHIC SNAPSHOT OF THE GLOBAL PERIPHERAL
VASCULAR DEVICES MARKET71
4PREMIUM INSIGHTS72
4.1PERIPHERAL VASCULAR DEVICES MARKET OVERVIEW72
FIGURE 19INCREASING PREVALENCE OF PERIPHERAL VASCULAR DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD72
4.2PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE72
FIGURE 20DRUG-ELUTING STENT PRODUCTS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 202172
4.3NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE OF ANGIOPLASTY STENT AND COUNTRY73
FIGURE 21THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN PERIPHERAL VASCULAR DEVICES MARKET IN 202173
4.4PERIPHERAL VASCULAR DEVICES MARKET: GEOGRAPHIC SNAPSHOT74
FIGURE 22CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD74
5MARKET OVERVIEW75
5.1INTRODUCTION75
5.2MARKET DYNAMICS75
FIGURE 23PERIPHERAL VASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES75
5.2.1DRIVERS76
5.2.1.1Rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases76
TABLE 2GERIATRIC POPULATION, BY REGION, 2015 VS. 203076
5.2.1.2Favorable reimbursement scenario for peripheral vascular procedures76
TABLE 3REIMBURSEMENT FOR PERIPHERAL VASCULAR PROCEDURES IN THE US77
5.2.1.3Increased number of product approvals77
TABLE 4PRODUCT APPROVALS IN THE PERIPHERAL VASCULAR DEVICES MARKET, 2017–202178
5.2.1.4Increased prevalence of diabetes78
TABLE 5DIABETES POPULATION, BY REGION, 2019 VS. 203079
5.2.1.5Rising rate of tobacco consumption79
TABLE 6THE TOP 10 COUNTRIES WITH THE HIGHEST SMOKING RATE (2021)79
5.2.1.6Growth in the incidence of obesity80
TABLE 7OBESITY RATE IN THE DEVELOPED COUNTRIES (2021)80
5.2.2RESTRAINTS80
5.2.2.1Increased number of product failures and recalls80
5.2.3OPPORTUNITIES81
5.2.3.1High growth rate in the emerging markets81
5.2.4CHALLENGES81
5.2.4.1Rise in the availability of alternative treatments81
5.2.4.2Dearth of skilled professionals with expertise in peripheral vascular devices82
5.2.5IMPACT OF THE COVID-19 PANDEMIC ON THE PERIPHERAL VASCULAR DEVICES MARKET82
5.3RANGES/SCENARIOS83
5.3.1PERIPHERAL VASCULAR DEVICES MARKET83
FIGURE 24PESSIMISTIC SCENARIO83
FIGURE 25OPTIMISTIC SCENARIO83
FIGURE 26REALISTIC SCENARIO84
5.4VALUE CHAIN ANALYSIS84
FIGURE 27MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE84
5.5SUPPLY CHAIN ANALYSIS85
FIGURE 28DIRECT DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES86
5.6PORTER’S FIVE FORCES ANALYSIS86
5.6.1THREAT OF NEW ENTRANTS86
5.6.2INTENSITY OF COMPETITIVE RIVALRY86
5.6.3BARGAINING POWER OF BUYERS87
5.6.4BARGAINING POWER OF SUPPLIERS87
5.6.5THREAT OF SUBSTITUTES87
5.7TECHNOLOGY ANALYSIS87
5.8REGULATORY ANALYSIS88
5.9PATENT ANALYSIS89
5.10TRADE ANALYSIS90
TABLE 8IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY, 2016–2020 (USD MILLION)90
TABLE 9EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY, 2016–2020 (USD MILLION)90
TABLE 10IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016–2020 (USD MILLION)91
TABLE 11EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016–2020 (USD MILLION)91
5.11PRICING ANALYSIS92
TABLE 12PRICE RANGE FOR PERIPHERAL VASCULAR DEVICES92
5.12ECOSYSTEM MAPPING92
5.12.1ROLE IN ECOSYSTEM93
FIGURE 29KEY PLAYERS IN THE PERIPHERAL VASCULAR DEVICE ECOSYSTEM93
5.13TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES94
5.13.1REVENUE SHIFT AND REVENUE POCKETS FOR PERIPHERAL VASCULAR DEVICES MARKET94
5.13.2REVENUE SHIFT FOR PERIPHERAL VASCULAR DEVICES94
6ANGIOPLASTY BALLOONS MARKET, BY TYPE95
6.1INTRODUCTION96
TABLE 13ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)96
TABLE 14ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)96
TABLE 15ANGIOPLASTY BALLOONS MARKET, BY REGION, 2016–2020 (USD MILLION)97
TABLE 16ANGIOPLASTY BALLOONS MARKET, BY REGION, 2021–2026 (USD MILLION)97
6.2OLD/NORMAL BALLOONS97
6.2.1OLD/NORMAL BALLOONS TO DOMINATE THE ANGIOPLASTY
BALLOONS MARKET97
TABLE 17OLD/NORMAL ANGIOPLASTY BALLOONS MARKET, BY REGION,
2016–2020 (USD MILLION)98
TABLE 18OLD/NORMAL ANGIOPLASTY BALLOONS MARKET, BY REGION,
2021–2026 (USD MILLION)98
6.3DRUG-ELUTING BALLOONS98
6.3.1DRUG-ELUTING BALLOONS TO WITNESS THE HIGHEST GROWTH IN THE ANGIOPLASTY BALLOONS MARKET98
TABLE 19DRUG-ELUTING BALLOONS MARKET, BY REGION,
2016–2020 (USD MILLION)99
TABLE 20DRUG-ELUTING BALLOONS MARKET, BY REGION,
2021–2026 (USD MILLION)99
6.4CUTTING AND SCORING BALLOONS99
6.4.1USE OF CUTTING BALLOONS IS LIMITED SINCE MEDICATION IS CONSIDERED THE PRIMARY TREATMENT FOR ATHEROSCLEROSIS99
TABLE 21CUTTING AND SCORING BALLOONS MARKET, BY REGION,
2016–2020 (USD MILLION)100
TABLE 22CUTTING AND SCORING BALLOONS MARKET, BY REGION,
2021–2026 (USD MILLION)100
7ANGIOPLASTY STENTS MARKET, BY TYPE101
7.1INTRODUCTION102
TABLE 23ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)102
TABLE 24ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)102
TABLE 25ANGIOPLASTY STENTS MARKET, BY REGION, 2016–2020 (USD MILLION)102
TABLE 26ANGIOPLASTY STENTS MARKET, BY REGION, 2021–2026 (USD MILLION)103
7.2DRUG-ELUTING STENTS103
7.2.1DRUG-ELUTING STENTS TO WITNESS A HIGHER ADOPTION DUE TO THE REDUCED RESTENOSIS RATE103
TABLE 27DRUG-ELUTING STENTS MARKET, BY REGION, 2016–2020 (USD MILLION)104
TABLE 28DRUG-ELUTING STENTS MARKET, BY REGION, 2021–2026 (USD MILLION)104
7.3BARE-METAL STENTS104
7.3.1INCREASING USE OF DRUG-ELUTING STENTS TO RESTRAIN MARKET GROWTH104
TABLE 29BARE-METAL STENTS MARKET, BY REGION, 2016–2020 (USD MILLION)105
TABLE 30BARE-METAL STENTS MARKET, BY REGION, 2021–2026 (USD MILLION)105
7.3.2BARE-METAL STENTS, BY DELIVERY PLATFORM105
TABLE 31BARE-METAL STENTS MARKET, BY DELIVERY PLATFORM,
2016–2020 (USD MILLION)105
TABLE 32BARE-METAL STENTS MARKET, BY DELIVERY PLATFORM,
2021–2026 (USD MILLION)106
7.3.2.1Balloon-expandable stents106
TABLE 33BALLOON-EXPANDABLE STENTS MARKET, BY REGION,
2016–2020 (USD MILLION)106
TABLE 34BALLOON-EXPANDABLE STENTS MARKET, BY REGION,
2021–2026 (USD MILLION)107
7.3.2.2Self-expandable stents107
TABLE 35SELF-EXPANDABLE STENTS MARKET, BY REGION,
2016–2020 (USD MILLION)107
TABLE 36SELF-EXPANDABLE STENTS MARKET, BY REGION,
2021–2026 (USD MILLION)108
8CATHETERS MARKET, BY TYPE109
8.1INTRODUCTION110
TABLE 37CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)110
TABLE 38CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)110
TABLE 39CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION)110
TABLE 40CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION)111
8.2ANGIOGRAPHY CATHETERS111
8.2.1ANGIOGRAPHY CATHETERS TO DOMINATE THE CATHETERS MARKET111
TABLE 41ANGIOGRAPHY CATHETERS MARKET, BY REGION,
2016–2020 (USD MILLION)112
TABLE 42ANGIOGRAPHY CATHETERS MARKET, BY REGION,
2021–2026 (USD MILLION)112
8.3GUIDING CATHETERS112
8.3.1GUIDING CATHETERS TO ACCOUNT FOR THE SECOND-LARGEST SHARE OF THE CATHETERS MARKET112
TABLE 43GUIDING CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION)113
TABLE 44GUIDING CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION)113
8.4IVUS/OCT CATHETERS113
8.4.1IVUS/OCT CATHETERS SEGMENT TO REGISTER THE HIGHEST GROWTH RATE113
TABLE 45IVUS/OCT CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION)114
TABLE 46IVUS/OCT CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION)114
9ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE115
9.1INTRODUCTION116
TABLE 47EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)116
TABLE 48EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)116
TABLE 49EVAR STENT GRAFTS MARKET, BY REGION, 2016–2020 (USD MILLION)116
TABLE 50EVAR STENT GRAFTS MARKET, BY REGION, 2021–2026 (USD MILLION)117
9.2ABDOMINAL AORTIC ANEURYSM STENT GRAFTS117
9.2.1ABDOMINAL AORTIC ANEURYSM STENT GRAFTS TO DOMINATE THE MARKET117
TABLE 51ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2016–2020 (USD MILLION)118
TABLE 52ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2021–2026 (USD MILLION)118
9.3THORACIC AORTIC ANEURYSM STENT GRAFTS118
9.3.1INCREASING INCIDENCE OF THORACIC AORTIC ANEURYSMS TO DRIVE MARKET GROWTH IN THE COMING YEARS118
TABLE 53THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2016–2020 (USD MILLION)119
TABLE 54THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2021–2026 (USD MILLION)119
10INFERIOR VENA CAVA FILTERS MARKET, BY TYPE120
10.1INTRODUCTION121
TABLE 55INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)121
TABLE 56INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)121
TABLE 57INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2016–2020 (USD MILLION)121
TABLE 58INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2021–2026 (USD MILLION)122
10.2RETRIEVABLE FILTERS122
10.2.1RETRIEVABLE FILTERS SEGMENT TO REGISTER A HIGHER GROWTH RATE122
TABLE 59RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2016–2020 (USD MILLION)122
TABLE 60RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2021–2026 (USD MILLION)123
10.3PERMANENT FILTERS123
10.3.1RISKS ASSOCIATED WITH PERMANENT FILTERS TO HAMPER THEIR SALES DURING THE FORECAST PERIOD123
TABLE 61PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2016–2020 (USD MILLION)123
TABLE 62PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2021–2026 (USD MILLION)124
11PLAQUE MODIFICATION DEVICES MARKET, BY TYPE125
11.1INTRODUCTION126
TABLE 63PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)126
TABLE 64PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)126
TABLE 65PLAQUE MODIFICATION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION)126
TABLE 66PLAQUE MODIFICATION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION)127
11.2ATHERECTOMY DEVICES127
11.2.1INCREASING INCIDENCE OF ATHEROSCLEROSIS AS A RESULT OF THE RISING GLOBAL PREVALENCE OF OBESITY TO DRIVE THE MARKET127
TABLE 67ATHERECTOMY DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION)128
TABLE 68ATHERECTOMY DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)128
11.3THROMBECTOMY DEVICES128
11.3.1GROWING DVT INCIDENCE TO DRIVE THE ADOPTION OF THROMBECTOMY DEVICES128
TABLE 69THROMBECTOMY DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION)129
TABLE 70THROMBECTOMY DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)129
12HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE130
12.1INTRODUCTION131
TABLE 71HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)131
TABLE 72HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)131
12.2EMBOLIC PROTECTION DEVICES131
12.2.1INCREASING INVESTMENTS IN NEW TECHNOLOGY AND INCREASING REGULATORY APPROVALS TO DRIVE MARKET GROWTH131
TABLE 73EMBOLIC PROTECTION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION)132
TABLE 74EMBOLIC PROTECTION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION)132
12.3CHRONIC TOTAL OCCLUSION (CTO) DEVICES133
12.3.1INCREASING INVESTMENTS IN THE DEVELOPMENT OF CTO DEVICES TO DRIVE MARKET GROWTH133
TABLE 75CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION)133
TABLE 76CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION)133
13OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE134
13.1INTRODUCTION135
TABLE 77OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)135
TABLE 78OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)135
TABLE 79OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION)136
TABLE 80OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION)136
13.2GUIDEWIRES136
TABLE 81GUIDEWIRES MARKET, BY REGION, 2016–2020 (USD MILLION)137
TABLE 82GUIDEWIRES MARKET, BY REGION, 2021–2026 (USD MILLION)137
13.3VASCULAR CLOSURE DEVICES137
TABLE 83VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION)138
TABLE 84VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION)138
13.4INTRODUCER SHEATHS138
TABLE 85INTRODUCER SHEATHS MARKET, BY REGION, 2016–2020 (USD MILLION)139
TABLE 86INTRODUCER SHEATHS MARKET, BY REGION, 2021–2026 (USD MILLION)139
13.5BALLOON INFLATION DEVICES139
TABLE 87BALLOON INFLATION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION)140
TABLE 88BALLOON INFLATION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION)140
14PERIPHERAL VASCULAR DEVICES MARKET, BY REGION141
14.1INTRODUCTION142
TABLE 89PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION)142
TABLE 90PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION)142
14.2NORTH AMERICA143
FIGURE 30NORTH AMERICA: MARKET SNAPSHOT143
TABLE 91NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2016–2020 (USD MILLION)144
TABLE 92NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)144
TABLE 93NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)144
TABLE 94NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)145
TABLE 95NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)145
TABLE 96NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)145
TABLE 97NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)146
TABLE 98NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)146
TABLE 99NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION)146
TABLE 100NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION)147
TABLE 101NORTH AMERICA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)147
TABLE 102NORTH AMERICA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)147
TABLE 103NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)147
TABLE 104NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)148
TABLE 105NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2016–2020 (USD MILLION)148
TABLE 106NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2021–2026 (USD MILLION)148
TABLE 107NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2016–2020 (USD MILLION)149
TABLE 108NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2021–2026 (USD MILLION)149
14.2.1FAVORABLE REIMBURSEMENT SCENARIO TO ENSURE DEVICE
ADOPTION IN THE US149
TABLE 109US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)151
TABLE 110US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)151
TABLE 111US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)151
TABLE 112US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)152
TABLE 113US: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)152
TABLE 114US: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)152
TABLE 115US: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)153
TABLE 116US: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)153
TABLE 117US: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)153
TABLE 118US: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)153
TABLE 119US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)154
TABLE 120US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)154
TABLE 121US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)154
TABLE 122US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)155
TABLE 123US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)155
TABLE 124US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)155
14.2.2CANADA156
14.2.2.1Rising prevalence of target diseases to drive market growth156
TABLE 125CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)156
TABLE 126CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)156
TABLE 127CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)157
TABLE 128CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)157
TABLE 129CANADA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)157
TABLE 130CANADA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)158
TABLE 131CANADA: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION)158
TABLE 132CANADA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION)158
TABLE 133CANADA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)159
TABLE 134CANADA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)159
TABLE 135CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)159
TABLE 136CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)160
TABLE 137CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)160
TABLE 138CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)160
TABLE 139CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)161
TABLE 140CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)161
14.3EUROPE161
TABLE 141EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY,
2016–2020 (USD MILLION)162
TABLE 142EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY,
2021–2026 (USD MILLION)162
TABLE 143EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)163
TABLE 144EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)163
TABLE 145EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)163
TABLE 146EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)163
TABLE 147EUROPE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)164
TABLE 148EUROPE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)164
TABLE 149EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)164
TABLE 150EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)164
TABLE 151EUROPE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)165
TABLE 152EUROPE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)165
TABLE 153EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)165
TABLE 154EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)165
TABLE 155EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)166
TABLE 156EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)166
TABLE 157EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)166
TABLE 158EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)167
14.3.1GERMANY167
14.3.1.1Increase in geriatric and obese populations contribute to device demand167
TABLE 159GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)168
TABLE 160GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)168
TABLE 161GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)168
TABLE 162GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)168
TABLE 163GERMANY: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)169
TABLE 164GERMANY: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)169
TABLE 165GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION)169
TABLE 166GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION)169
TABLE 167GERMANY: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)170
TABLE 168GERMANY: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)170
TABLE 169GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)170
TABLE 170GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)170
TABLE 171GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)171
TABLE 172GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)171
TABLE 173GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)171
TABLE 174GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)172
14.3.2FRANCE172
14.3.2.1Incidence of PE and DVT to increase owing to the growth of France’s geriatric population172
TABLE 175FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)173
TABLE 176FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)173
TABLE 177FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)173
TABLE 178FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)173
TABLE 179FRANCE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)174
TABLE 180FRANCE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)174
TABLE 181FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)174
TABLE 182FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)174
TABLE 183FRANCE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)175
TABLE 184FRANCE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)175
TABLE 185FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)175
TABLE 186FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)175
TABLE 187FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)176
TABLE 188FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)176
TABLE 189FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)176
TABLE 190FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)177
14.3.3UK177
14.3.3.1Increasing incidence of peripheral vascular diseases to support market growth in the UK177
TABLE 191UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)178
TABLE 192UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)178
TABLE 193UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)178
TABLE 194UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)179
TABLE 195UK: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)179
TABLE 196UK: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)179
TABLE 197UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)179
TABLE 198UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)180
TABLE 199UK: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)180
TABLE 200UK: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)180
TABLE 201UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)180
TABLE 202UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)181
TABLE 203UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)181
TABLE 204UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)181
TABLE 205UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)182
TABLE 206UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)182
14.3.4SPAIN182
14.3.4.1Rising geriatric population to increase the demand for peripheral vascular devices182
TABLE 207SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)183
TABLE 208SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)183
TABLE 209SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)183
TABLE 210SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)184
TABLE 211SPAIN: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)184
TABLE 212SPAIN: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)184
TABLE 213SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)184
TABLE 214SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)185
TABLE 215SPAIN: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)185
TABLE 216SPAIN: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)185
TABLE 217SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)185
TABLE 218SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)186
TABLE 219SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)186
TABLE 220SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)186
TABLE 221SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)187
TABLE 222SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)187
14.3.5ITALY187
14.3.5.1Increasing health expenditure and rising diabetes prevalence to drive market growth187
TABLE 223ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)188
TABLE 224ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)188
TABLE 225ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)188
TABLE 226ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)189
TABLE 227ITALY: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)189
TABLE 228ITALY: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)189
TABLE 229ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)189
TABLE 230ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)190
TABLE 231ITALY: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)190
TABLE 232ITALY: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)190
TABLE 233ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)190
TABLE 234ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)191
TABLE 235ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)191
TABLE 236ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)191
TABLE 237ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)192
TABLE 238ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)192
14.3.6REST OF EUROPE192
TABLE 239ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)193
TABLE 240ROE: PERCENTAGE OF GERIATRIC POPULATION TO THE TOTAL POPULATION, BY COUNTRY, 2015 VS. 2030 (MILLION)193
TABLE 241ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)194
TABLE 242ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)194
TABLE 243ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)194
TABLE 244ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)194
TABLE 245ROE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)195
TABLE 246ROE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)195
TABLE 247ROE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)195
TABLE 248ROE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)196
TABLE 249ROE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)196
TABLE 250ROE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)196
TABLE 251ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)196
TABLE 252ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)197
TABLE 253ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)197
TABLE 254ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)197
TABLE 255ROE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)198
TABLE 256ROE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)198
14.4ASIA PACIFIC198
FIGURE 31ASIA PACIFIC: MARKET SNAPSHOT199
TABLE 257ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2016–2020 (USD MILLION)200
TABLE 258ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)200
TABLE 259ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)200
TABLE 260ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)201
TABLE 261ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)201
TABLE 262ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)201
TABLE 263ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)201
TABLE 264ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)202
TABLE 265ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION)202
TABLE 266ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION)202
TABLE 267ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)202
TABLE 268ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)203
TABLE 269ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)203
TABLE 270ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)203
TABLE 271ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2016–2020 (USD MILLION)204
TABLE 272ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2021–2026 (USD MILLION)204
TABLE 273ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)204
TABLE 274ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)205
14.4.1JAPAN205
14.4.1.1Presence of a large geriatric population to support market growth205
TABLE 275JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)206
TABLE 276JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)206
TABLE 277JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)206
TABLE 278JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)206
TABLE 279JAPAN: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)207
TABLE 280JAPAN: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)207
TABLE 281JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)207
TABLE 282JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)207
TABLE 283JAPAN: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)208
TABLE 284JAPAN: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)208
TABLE 285JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)208
TABLE 286JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)208
TABLE 287JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)209
TABLE 288JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)209
TABLE 289JAPAN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)209
TABLE 290JAPAN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)210
14.4.2CHINA210
14.4.2.1Growing target patient population to drive market growth210
TABLE 291CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)211
TABLE 292CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)211
TABLE 293CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)211
TABLE 294CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)211
TABLE 295CHINA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)212
TABLE 296CHINA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)212
TABLE 297CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)212
TABLE 298CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)212
TABLE 299CHINA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)213
TABLE 300CHINA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)213
TABLE 301CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)213
TABLE 302CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)213
TABLE 303CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)214
TABLE 304CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)214
TABLE 305CHINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)214
TABLE 306CHINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)215
14.4.3INDIA215
14.4.3.1Increasing prevalence of diabetes to drive the adoption of peripheral vascular devices215
TABLE 307INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)216
TABLE 308INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)216
TABLE 309INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)216
TABLE 310INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)216
TABLE 311INDIA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)217
TABLE 312INDIA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)217
TABLE 313INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)217
TABLE 314INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)217
TABLE 315INDIA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)218
TABLE 316INDIA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)218
TABLE 317INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)218
TABLE 318INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)218
TABLE 319INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)219
TABLE 320INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)219
TABLE 321INDIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)219
TABLE 322INDIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)220
14.4.4REST OF ASIA PACIFIC220
TABLE 323REST OF ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)221
TABLE 324REST OF ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)221
TABLE 325REST OF ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)221
TABLE 326REST OF ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)222
TABLE 327REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE,
2016–2020 (USD MILLION)222
TABLE 328REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE,
2021–2026 (USD MILLION)222
TABLE 329REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION)223
TABLE 330REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION)223
TABLE 331REST OF ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE,
2016–2020 (USD MILLION)223
TABLE 332REST OF ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE,
2021–2026 (USD MILLION)223
TABLE 333REST OF ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)224
TABLE 334REST OF ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)224
TABLE 335REST OF ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)224
TABLE 336REST OF ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)225
TABLE 337REST OF ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2016–2020 (USD MILLION)225
TABLE 338REST OF ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)225
14.5REST OF THE WORLD226
TABLE 339ROW: PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION)226
TABLE 340ROW: PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION)226
TABLE 341ROW: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)226
TABLE 342ROW: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)227
TABLE 343ROW: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)227
TABLE 344ROW: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)227
TABLE 345ROW: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)227
TABLE 346ROW: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)228
TABLE 347ROW: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)228
TABLE 348ROW: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)228
TABLE 349ROW: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)228
TABLE 350ROW: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)229
TABLE 351ROW: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)229
TABLE 352ROW: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)229
TABLE 353ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)229
TABLE 354ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)230
TABLE 355ROW: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)230
TABLE 356ROW: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)230
14.5.1LATIN AMERICA231
TABLE 357LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2016–2020 (USD MILLION)231
TABLE 358LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)232
TABLE 359LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)232
TABLE 360LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)232
TABLE 361LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)233
TABLE 362LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)233
TABLE 363LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)233
TABLE 364LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)233
TABLE 365LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION)234
TABLE 366LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION)234
TABLE 367LATIN AMERICA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)234
TABLE 368LATIN AMERICA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)234
TABLE 369LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)235
TABLE 370LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)235
TABLE 371LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2016–2020 (USD MILLION)235
TABLE 372LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2021–2026 (USD MILLION)236
TABLE 373LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)236
TABLE 374LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)236
14.5.1.1Brazil237
14.5.1.1.1Brazil to dominate the Latin American peripheral vascular devices market237
TABLE 375BRAZIL: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020(USD MILLION)237
TABLE 376BRAZIL: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)237
TABLE 377BRAZIL: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)238
TABLE 378BRAZIL: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)238
TABLE 379BRAZIL: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)238
TABLE 380BRAZIL: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)238
TABLE 381BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)239
TABLE 382BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)239
TABLE 383BRAZIL: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)239
TABLE 384BRAZIL: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)239
TABLE 385BRAZIL: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)240
TABLE 386BRAZIL: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)240
TABLE 387BRAZIL: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)240
TABLE 388BRAZIL: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)240
TABLE 389BRAZIL: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2016–2020 (USD MILLION)241
TABLE 390BRAZIL: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2026–2026 (USD MILLION)241
14.5.1.2Mexico241
14.5.1.2.1Mexico to account for the second-largest share in the Latin American peripheral vascular devices market241
TABLE 391MEXICO: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)242
TABLE 392MEXICO: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)242
TABLE 393MEXICO: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)242
TABLE 394MEXICO: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)243
TABLE 395MEXICO: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)243
TABLE 396MEXICO: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)243
TABLE 397MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION)243
TABLE 398MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION)244
TABLE 399MEXICO: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)244
TABLE 400MEXICO: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)244
TABLE 401MEXICO: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)244
TABLE 402MEXICO: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)245
TABLE 403MEXICO: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)245
TABLE 404MEXICO: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)245
TABLE 405MEXICO: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)246
TABLE 406MEXICO: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)246
14.5.1.3Colombia246
14.5.1.3.1Increasing prevalence of peripheral artery diseases to support market growth246
TABLE 407COLOMBIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)247
TABLE 408COLOMBIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)247
TABLE 409COLOMBIA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)247
TABLE 410COLOMBIA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)247
TABLE 411COLOMBIA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)248
TABLE 412COLOMBIA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)248
TABLE 413COLOMBIA: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION)248
TABLE 414COLOMBIA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION)248
TABLE 415COLOMBIA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)249
TABLE 416COLOMBIA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)249
TABLE 417COLOMBIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)249
TABLE 418COLOMBIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)249
TABLE 419COLOMBIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)250
TABLE 420COLOMBIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)250
TABLE 421COLOMBIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)250
TABLE 422COLOMBIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)251
14.5.1.4Argentina251
14.5.1.4.1Increasing prevalence of obesity to support market growth251
TABLE 423ARGENTINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)251
TABLE 424ARGENTINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)252
TABLE 425ARGENTINA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)252
TABLE 426ARGENTINA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)252
TABLE 427ARGENTINA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION)252
TABLE 428ARGENTINA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION)253
TABLE 429ARGENTINA: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION)253
TABLE 430ARGENTINA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION)253
TABLE 431ARGENTINA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION)253
TABLE 432ARGENTINA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION)254
TABLE 433ARGENTINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)254
TABLE 434ARGENTINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)254
TABLE 435ARGENTINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)255
TABLE 436ARGENTINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)255
TABLE 437ARGENTINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)255
TABLE 438ARGENTINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)256
14.5.1.5Rest of Latin America256
TABLE 439REST OF LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION)256
TABLE 440REST OF LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION)256
TABLE 441REST OF LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)257
TABLE 442REST OF LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)257
TABLE 443REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE,
2016–2020 (USD MILLION)257
TABLE 444REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE,
2021–2026 (USD MILLION)258
TABLE 445REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION)258
TABLE 446REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION)258
TABLE 447REST OF LATIN AMERICA: IVC FILTERS MARKET, BY TYPE,
2016–2020 (USD MILLION)259
TABLE 448REST OF LATIN AMERICA: IVC FILTERS MARKET, BY TYPE,
2021–2026 (USD MILLION)259
TABLE 449REST OF LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET,
BY TYPE, 2016–2020 (USD MILLION)259
TABLE 450REST OF LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET,
BY TYPE, 2021–2026 (USD MILLION)259
TABLE 451REST OF LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)260
TABLE 452REST OF LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)260
TABLE 453REST OF LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)260
TABLE 454REST OF LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)261
14.5.2MIDDLE EAST & AFRICA261
14.5.2.1Increasing prevalence of diabetes to drive market growth261
TABLE 455MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION)262
TABLE 456MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION)262
TABLE 457MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)262
TABLE 458MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)263
TABLE 459MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE,
2016–2020 (USD MILLION)263
TABLE 460MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE,
2021–2026 (USD MILLION)263
TABLE 461MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION)264
TABLE 462MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION)264
TABLE 463MIDDLE EAST & AFRICA: IVC FILTERS MARKET, BY TYPE,
2016–2020 (USD MILLION)264
TABLE 464MIDDLE EAST & AFRICA: IVC FILTERS MARKET, BY TYPE,
2021–2026 (USD MILLION)264
TABLE 465MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)265
TABLE 466MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)265
TABLE 467MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)265
TABLE 468MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)266
TABLE 469MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)266
TABLE 470MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)266
15COMPETITIVE LANDSCAPE267
15.1OVERVIEW267
15.2KEY PLAYER STRATEGIES/RIGHT TO WIN267
TABLE 471OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE PERIPHERAL VASCULAR DEVICES MARKET267
15.3MARKET SHARE ANALYSIS268
TABLE 472PERIPHERAL VASCULAR DEVICES MARKET: DEGREE OF COMPETITION268
15.4COMPANY EVALUATION MATRIX269
15.4.1STARS269
15.4.2EMERGING LEADERS269
15.4.3PERVASIVE PLAYERS269
15.4.4PARTICIPANTS269
FIGURE 32COMPANY EVALUATION MATRIX: PERIPHERAL VASCULAR DEVICES MARKET270
15.5COMPANY EVALUATION MATRIX (SMES/START-UPS)271
15.5.1PROGRESSIVE COMPANIES271
15.5.2STARTING BLOCKS271
15.5.3RESPONSIVE COMPANIES271
15.5.4DYNAMIC COMPANIES271
FIGURE 33COMPANY EVALUATION MATRIX: PERIPHERAL VASCULAR DEVICES MARKET (SMES & START-UPS)272
15.6COMPANY FOOTPRINT ANALYSIS273
TABLE 473OVERALL FOOTPRINT OF COMPANIES IN THE PERIPHERAL VASCULAR DEVICES MARKET273
TABLE 474PRODUCT FOOTPRINT OF COMPANIES274
15.7COMPETITIVE SCENARIO276
16COMPANY PROFILES280
16.1KEY PLAYERS280
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
16.1.1MEDTRONIC280
TABLE 475MEDTRONIC: BUSINESS OVERVIEW280
FIGURE 34MEDTRONIC: COMPANY SNAPSHOT (2020)281
16.1.2BOSTON SCIENTIFIC CORPORATION286
TABLE 476BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW286
FIGURE 35BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2020)287
16.1.3ABBOTT291
TABLE 477ABBOTT: BUSINESS OVERVIEW291
FIGURE 36ABBOTT: COMPANY SNAPSHOT (2020)292
16.1.4BECTON, DICKINSON AND COMPANY295
TABLE 478BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW295
FIGURE 37BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)296
16.1.5TERUMO CORPORATION299
TABLE 479TERUMO CORPORATION: BUSINESS OVERVIEW299
FIGURE 38TERUMO CORPORATION: COMPANY SNAPSHOT (2020)300
16.1.6CORDIS (A SUBSIDIARY OF CARDINAL HEALTH)303
TABLE 480CORDIS: BUSINESS OVERVIEW303
FIGURE 39CARDINAL HEALTH: COMPANY SNAPSHOT (2020)304
16.1.7B. BRAUN MELSUNGEN AG308
TABLE 481B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW308
FIGURE 40B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020)309
16.1.8MERIT MEDICAL SYSTEMS311
TABLE 482MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW311
FIGURE 41MERIT MEDICAL: COMPANY SNAPSHOT (2020)312
16.1.9PENUMBRA, INC.314
TABLE 483PENUMBRA, INC: BUSINESS OVERVIEW314
FIGURE 42PENUMBRA, INC.: COMPANY SNAPSHOT (2020)315
16.1.10KONINKLIJKE PHILIPS N.V.317
TABLE 484KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW317
FIGURE 43KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)318
16.1.11IVASCULAR S.L.U.320
TABLE 485IVASCULAR S.L.U.: BUSINESS OVERVIEW320
16.1.12BIOSENSORS INTERNATIONAL GROUP, LTD.322
TABLE 486BIOSENSORS INTERNATIONAL GROUP, LTD.: BUSINESS OVERVIEW322
16.1.13BIOTRONIK323
TABLE 487BIOTRONIK: BUSINESS OVERVIEW323
16.1.14AMG INTERNATIONAL GMBH (A SUBSIDIARY OF Q3 MEDICAL)325
TABLE 488AMG INTERNATIONAL: BUSINESS OVERVIEW325
16.1.15ENDOCOR GMBH326
TABLE 489ENDOCOR GMBH: BUSINESS OVERVIEW326
16.2START-UPS/SME PLAYERS328
16.2.1MERIL LIFE SCIENCES PVT. LTD.328
TABLE 490MERIL LIFE SCIENCES PVT.LTD.: COMPANY OVERVIEW328
16.2.2ALVIMEDICA329
TABLE 491ALVIMEDICA: COMPANY OVERVIEW329
16.2.4CARDIONOVUM GMBH330
TABLE 492CARDIONOVUM GMBH: COMPANY OVERVIEW330
16.2.6SMT331
TABLE 493SMT: COMPANY OVERVIEW331
16.2.8MEDINOL LTD.332
TABLE 494MEDINOL LTD.: COMPANY OVERVIEW332
16.2.9ANDRAMED GMBH.333
TABLE 495ANDRAMED GMBH: COMPANY OVERVIEW333
16.2.10COOK334
TABLE 496COOK: COMPANY OVERVIEW334
16.2.12REX MEDICAL336
TABLE 497REX MEDICAL: COMPANY OVERVIEW336
16.2.14QMD337
TABLE 498QMD.: COMPANY OVERVIEW337
16.2.15BROSMED MEDICAL338
TABLE 499BROSMED MEDICAL: COMPANY OVERVIEW338
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
17APPENDIX339
17.1DISCUSSION GUIDE339
17.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL344
17.3AVAILABLE CUSTOMIZATIONS346
17.4RELATED REPORTS346
17.5AUTHOR DETAILS347